Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... associated with both HER-2/neu expression and macrophage infiltration in pre-invasive ductal carcinoma in situ. The gene expression signature associated with loss of PTHrP expression in vivo ...
2009 NOV 16 ... woman's lifetime risk of breast cancer was 1 in 12 in 1980; today it is 1 in 8. And, if ductal carcinoma in situ is included, the risk of being diagnosed with breast cancer, like prostate cancer, has ...
2009 NOV 9 ... containing atypical ductal or lobular hyperplasia. Six patients (1.1 percent) had ductal carcinoma in situ and four patients (0.7 percent) had lobular carcinoma in situ. No occult invasive breast ...
2009 NOV 1 ... published their study in Cancer Cell (14-3-3 zeta Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal Transition. ...
2009 NOV 23 ... 52 were infiltrating ductal cancer, 5 were infiltrating lobular cancer, 2 were ductal carcinoma in situ, and 2 were other histologic types. When pathologic size was used to determine the ...
2009 NOV 9 ... the human breast. Scoring tissue sections of duct carcinomainsitu (DCIS) or invasive ductalcarcinoma (IDC) that also harboured regions of normal breast tissue, a loss of ALX4 (p ...
2009 NOV 23 ... "Synchronous preinvasive lesions (atypical ductal hyperplasia and/or ductal carcinoma in situ) and invasive ductal breast carcinoma from 52 patients, together with pure lesions from ...
2009 NOV 9 ... call toll-free for subscription information, 800-876-8633, extension 9751. Ductal Carcinoma In Situ -- A Highly Treatable Breast Cancer; Questions Remain on how Aggressively to Treat ...
2009 NOV 23 ... of cancers with HER-2 overexpression. Tissue microarrays were created from 71 invasive ductal carcinomas of the breast categorized into subclasses, and telomere lengths were directly ... Research findings, 'The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression,' are discussed in a new report. ... into subclasses, and telomere lengths were directly assessed using fluorescence in situ hybridization with combined promyelocytic leukemia (PML) protein immunofluorescence. The ...
2009 NOV 2 ... mammography for initial screening and subsequent screening, for invasive cancer and ductal carcinoma in situ, and across all age groups. The cancer detection rate for cancers presenting as ...
2009 NOV 23 ... (16/142). Of the cancerous lesions, 56% were invasive carcinomas (9/16) and 44% were ductal carcinomas insitu (7/16). Fourteen percent of the discovered lesions (28/197) were ... risk and included atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma in situ, and radial scar. In total, occult cancerous and high-risk lesions were ...
2009 NOV 23 ... Baseline screening mammography identified a 4 mm cluster of microcalcifications and ductal carcinoma in situ (DCIS) was confirmed by stereotactic biopsy. Diagnosis. DCIS in a male BRCA2 mutation ...
2009 NOV 23 ... (2+) or strong (3+) in 13 (34%) and 25 (66%) foci, respectively. ME cells surrounding ductal carcinoma in situ (DCIS) displayed weaker (1+ to 2+) podoplanin expression with 26 (72%) foci showing only ...
2009 NOV 23 ... test, exact McNemar's test and Page's L test were used. All 10 cases were invasive ductal carcinomas. Q score >or=6 was identified in five cases for estrogen receptor and four ... United States, Buffalo, Breast Cancer Therapy, Biotechnology, Breast Cancer, Breast Carcinoma, Cancer Biomarkers, Carcinoma Biomarkers, Hormones, Oncology, Pathology, Progesterone, ... Estrogen and progesterone receptors and HER2 immunohistochemistry and fluorescence in situ hybridization were carried out. Statistical analyses including non-parametric sign test, ...
2009 NOV 9 ... - n = 8); florid hyperplasia without atypia (FH - n = 17); fibroadenoma (FIB - n = 17); ductal carcinoma in situ (DCIS - n = 10) and infiltrating ductal carcinoma (IDC - n = 15) were processed for ...
2009 NOV 2 ... normal breast skin and lobules and in the breast skin and cancer tissue of patients with ductal carcinoma in situ (DCIS) and invasive ductal carcinomas (IDCs)," wrote J.S. Lawson and colleagues, ...
2009 NOV 9 ... therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma in situ ( DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen ...
